Concepedia

Louise Buur

LB

Statistics

Publications

2

Citations

54

H-Index

2

Active since

2024

Affiliations

Lundbeck (Denmark)(Current)

Louise Buur is an author at Lundbeck (Denmark) specializing in immunotherapy, target engagement assessment, and drug-target engagement.

ORCID

Publications per year

2024–2025

2

Publications

2

Randomized Phase I Trial of the α‐Synuclein Antibody Lu AF82422

Louise Buur, Jonas Wiedemann, Frank Larsen et al. · Movement Disorders · 2024 · 44 citations · Full text

, , +17

Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies

Pekka Kallunki, Florence Sotty, Katarina Willén et al. · npj Parkinson s Disease · 2025 · 10 citations · Full text

, , +17

1–2 of 2